Biblio
JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis. Blood. 2014.
. Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway. Anticancer Drugs. 2021.
.